Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 484357, 10 pages
http://dx.doi.org/10.1155/2015/484357
Research Article

Cardiac-Restricted IGF-1Ea Overexpression Reduces the Early Accumulation of Inflammatory Myeloid Cells and Mediates Expression of Extracellular Matrix Remodelling Genes after Myocardial Infarction

1National Heart and Lung Institute, Imperial College London, London, UK
2Australian Regenerative Medicine Institute, EMBL Australia, Monash University, Clayton, Melbourne, VIC, Australia
3The Jackson Laboratory, Bar Harbor, ME, USA

Received 23 July 2015; Accepted 13 September 2015

Academic Editor: Michael Schnoor

Copyright © 2015 Enrique Gallego-Colon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Heart disease and stroke statistics—2014 update: a report from the American heart association,” Circulation, vol. 129, pp. e28–e292, 2014. View at Publisher · View at Google Scholar
  2. N. G. Frangogiannis, “Regulation of the inflammatory response in cardiac repair,” Circulation Research, vol. 110, no. 1, pp. 159–173, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. N. G. Frangogiannis, “The inflammatory response in myocardial injury, repair, and remodelling,” Nature Reviews Cardiology, vol. 11, no. 5, pp. 255–265, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Shavlakadze, N. Winn, N. Rosenthal, and M. D. Grounds, “Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle,” Growth Hormone and IGF Research, vol. 15, no. 1, pp. 4–18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Rotwein, K. M. Pollock, D. K. Didier, and G. G. Krivi, “Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides,” Journal of Biological Chemistry, vol. 261, no. 11, pp. 4828–4832, 1986. View at Google Scholar · View at Scopus
  6. J. G. Simmons, J. J. Van Wyk, E. C. Hoyt, and P. K. Lund, “Multiple transcription start sites in the rat insulin-like growth factor-I gene Give rise to IGF-I mRNAs that encode different IGF-I precursors and are processed differently in vitvo,” Growth Factors, vol. 9, no. 3, pp. 205–221, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. G. I. Bell, M. M. Stempien, N. M. Fong, and L. B. Rall, “Sequences of liver cDNAs encoding two different mouse insulin-like growth factor I precursors,” Nucleic Acids Research, vol. 14, no. 20, pp. 7873–7882, 1986. View at Publisher · View at Google Scholar · View at Scopus
  8. M. S. Hede, E. Salimova, A. Piszczek et al., “E-peptides control bioavailability of IGF-1,” PLoS ONE, vol. 7, no. 12, Article ID e51152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. P. Santini, L. Tsao, L. Monassier et al., “Enhancing repair of the mammalian heart,” Circulation Research, vol. 100, no. 12, pp. 1732–1740, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Vinciguerra, M. P. Santini, W. C. Claycomb, A. G. Ladurner, and N. Rosenthal, “Local IGF-1 isoform protects cardiomyocytes from hypertrophic and oxidative stresses via SirT1 activity,” Aging, vol. 2, no. 1, pp. 43–62, 2010. View at Google Scholar · View at Scopus
  11. D. Vanhoutte, M. Schellings, Y. Pinto, and S. Heymans, “Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window,” Cardiovascular Research, vol. 69, no. 3, pp. 604–613, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. B. Caulfield and T. K. Borg, “The collagen network of the heart,” Laboratory Investigation, vol. 40, no. 3, pp. 364–372, 1979. View at Google Scholar · View at Scopus
  13. B. I. Jugdutt, “Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways,” Current Drug Targets—Cardiovascular & Haematological Disorders, vol. 3, no. 1, pp. 1–30, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. B. I. Jugdutt, “Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?” Circulation, vol. 108, no. 11, pp. 1395–1403, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Nahrendorf and F. K. Swirski, “Monocyte and macrophage heterogeneity in the heart,” Circulation Research, vol. 112, no. 12, pp. 1624–1633, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Leuschner, P. J. Rauch, T. Ueno et al., “Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis,” The Journal of Experimental Medicine, vol. 209, no. 1, pp. 123–137, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Yan, A. Anzai, Y. Katsumata et al., “Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction,” Journal of Molecular and Cellular Cardiology, vol. 62, pp. 24–35, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Frantz and M. Nahrendorf, “Cardiac macrophages and their role in ischemic heart disease,” Cardiovascular Research, vol. 102, no. 2, pp. 240–248, 2014. View at Publisher · View at Google Scholar
  19. Q. Cao, Y. Wang, D. Zheng et al., “IL-10/TGF-β-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis,” Journal of the American Society of Nephrology, vol. 21, no. 6, pp. 933–942, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Johannesson, S. Sattler, E. Semenova et al., “Insulin-like growth factor-1 induces regulatory T cell-mediated suppression of allergic contact dermatitis in mice,” Disease Models & Mechanisms, vol. 7, no. 8, pp. 977–985, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Bilbao, L. Luciani, B. Johannesson, A. Piszczek, and N. Rosenthal, “Insulin-like growth factor-1 stimulates regulatory T cells and suppresses autoimmune disease,” EMBO Molecular Medicine, vol. 6, no. 11, pp. 1423–1435, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Oh, S. B. Bradfute, T. D. Gallardo et al., “Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 21, pp. 12313–12318, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Philippou, E. Papageorgiou, G. Bogdanis et al., “Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: characterization of the MGF E peptide actions in vitro,” In Vivo, vol. 23, no. 4, pp. 567–576, 2009. View at Google Scholar · View at Scopus
  24. S. Sanz, J. B. Pucilowska, S. Liu et al., “Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury,” Gut, vol. 54, no. 1, pp. 134–141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. M. P. Santini, L. Tsao, L. Monassier et al., “Enhancing repair of the mammalian heart,” Circulation Research, vol. 100, no. 12, pp. 1732–1740, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Tacke, D. Alvarez, T. J. Kaplan et al., “Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques,” Journal of Clinical Investigation, vol. 117, no. 1, pp. 185–194, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. L. M. Carlin, E. G. Stamatiades, C. Auffray et al., “Nr4a1-dependent Ly6Clow monocytes monitor endothelial cells and orchestrate their disposal,” Cell, vol. 153, no. 2, pp. 362–375, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. N. V. Serbina and E. G. Pamer, “Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2,” Nature Immunology, vol. 7, no. 3, pp. 311–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Hayashidani, H. Tsutsui, M. Ikeuchi et al., “Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 285, no. 3, pp. H1229–H1235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Ducharme, S. Frantz, M. Aikawa et al., “Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction,” Journal of Clinical Investigation, vol. 106, no. 1, pp. 55–62, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. K. T. Weber, “Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation,” Circulation, vol. 96, no. 11, pp. 4065–4082, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. W. Iraqi, P. Rossignol, M. Angioi et al., “Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study,” Circulation, vol. 119, no. 18, pp. 2471–2479, 2009. View at Publisher · View at Google Scholar
  33. R. Eschalier, M. Fertin, R. Fay et al., “Extracellular matrix turnover biomarkers predict long-term left ventricular remodeling after myocardial infarction insights from the reve-2 study,” Circulation: Heart Failure, vol. 6, no. 6, pp. 1199–1205, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. J. G. Simmons, J. B. Pucilowska, T. O. Keku, and P. K. Lund, “IGF-I and TGF-β1 have distinct effects on phenotype and proliferation of intestinal fibroblasts,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 283, no. 3, pp. G809–G818, 2002. View at Google Scholar · View at Scopus
  35. C. F. Hung, M. G. Rohani, S.-S. Lee, P. Chen, and L. M. Schnapp, “Role of IGF-1 pathway in lung fibroblast activation,” Respiratory Research, vol. 14, no. 1, article 102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Nahrendorf, F. K. Swirski, E. Aikawa et al., “The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions,” The Journal of Experimental Medicine, vol. 204, no. 12, pp. 3037–3047, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. F. L. Chen, Z. H. Yang, Y. Liu et al., “Berberine inhibits the expression of TNFα, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARγ pathway,” Endocrine, vol. 33, no. 3, pp. 331–337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Tonkin, L. Temmerman, R. D. Sampson et al., “Monocyte/macrophage-derived IGF-1 orchestrates murine skeletal muscle regeneration and modulates autocrine polarization,” Molecular Therapy, vol. 23, no. 7, pp. 1189–1200, 2015. View at Publisher · View at Google Scholar
  39. T. Heidt, G. Courties, P. Dutta et al., “Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction,” Circulation Research, vol. 115, no. 2, pp. 284–295, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Epelman, K. J. Lavine, and G. J. Randolph, “Origin and functions of tissue macrophages,” Immunity, vol. 41, no. 1, pp. 21–35, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. A. R. Pinto, J. W. Godwin, and N. A. Rosenthal, “Macrophages in cardiac homeostasis, injury responses and progenitor cell mobilisation,” Stem Cell Research, vol. 13, no. 3, pp. 705–714, 2014. View at Publisher · View at Google Scholar · View at Scopus